Mesenchymal stem cell

Phase 1
Lung Transplant
Intervention Type
Intravenous (IV) Injection
Funder Type
Organization | University

Drug Details

Mesenchymal stem cells derived from allogeneic, bone marrow.

Study Purpose

To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS)

This drug has no clinical trials actively recruiting patients at this time.


footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >